Novartis AG (NVS)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account
Sell

$111.45

Buy

$111.49

arrow-down$-2.02 (-1.78%)

Novartis AG is a part of the healthcare industry. Its main activity is to research and develop healthcare products and pharmaceuticals such as oncology medicines, generic and biosimilar medicines and eye care devices.
Prices updated at 01 May 2025, 20:07 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Most recent dividend payment

3.994
Cash Dividend
12 Mar 2025
20 Feb 2025
12 Mar 2025
25 Apr 2025

Total dividend yield

Created with Highcharts 7.2.2Total yield (%)Total yield (%)2021202220232024202502.557.510

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20253.9940-
20243.73950.07
20233.49870.05
20223.32530.04
20213.19910.04
20203.08740.09
20192.8341-0.03
20182.93650.08
20172.71780.00
20162.71790.02

Total dividend yield data table

YearDividend yield (%)Buyback yield (%)Total yield (%)
20253.524.427.94
20243.843.527.36
20233.474.918.38
20223.674.177.84
20213.662.386.04
20203.270.503.77
20192.992.695.68
20183.421.384.80
20173.242.415.65
20163.732.516.24

Dividend per share

Created with Highcharts 7.2.2Dividend per shareDividend per share20212022202320242025012345

% of earnings paid to shareholders

Created with Highcharts 7.2.2Payout ratio (%)Payout ratio (%)202120222023202420250255075100

Dividend per share data table

YearDividend per share
20253.9940
20243.7395
20233.4987
20223.3253
20213.1991
20203.0874
20192.8341
20182.9365
20172.7178
20162.7179

% of earnings paid to shareholders data table

YearPayout ratio (%)
202562.60
202465.26
202390.64
202234.28
202173.88
202099.91
201993.54
201851.43
201796.72
201695.70
Latest Financial Report as of 30 Apr 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.